RENAL ALLOGRAFT RECIPIENTS
Clinical trials for RENAL ALLOGRAFT RECIPIENTS explained in plain language.
Never miss a new study
Get alerted when new RENAL ALLOGRAFT RECIPIENTS trials appear
Sign up with your email to follow new studies for RENAL ALLOGRAFT RECIPIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a drug switch help teen kidney transplant patients keep their grafts longer?
Disease control Recruiting nowThis study looks at whether switching teen kidney transplant patients (ages 12-17) from standard anti-rejection drugs to a newer medication called belatacept can help preserve kidney function and improve how consistently they take their medicine. About 102 participants will be ra…
Matched conditions: RENAL ALLOGRAFT RECIPIENTS
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 05, 2026 11:56 UTC
-
No-Needle kidney check: MRI could replace biopsies for transplant patients
Knowledge-focused Recruiting nowThis study explores a new, non-invasive MRI method to monitor kidney health after a transplant. Instead of relying on blood tests or invasive biopsies, the MRI measures blood flow and oxygen levels in the kidney. The goal is to detect problems earlier and more accurately, improvi…
Matched conditions: RENAL ALLOGRAFT RECIPIENTS
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated May 11, 2026 20:53 UTC